| BMP-2 | Human bone morphogenetic protein 2 |
| CH–GA | Chitosan-glycolic acid |
| CLM | Chitosan-based luminescent/magnetic |
| CMAs | Myristic acid and chitosan-based nanogels |
| CMC | Carboxymethyl chitosan |
| CMCS | Carboxymethyl chitosan |
| CS-g | Chitosan grafted |
| DD | Degree of deacetylation |
| DMA | 2,3-dimethylmaleic anhydride |
| DNA | Deoxyribonucleic acid |
| EMA | European Medicine Agency |
| FDA | Food and Drug Administration |
| GMP | Good Manufacturing Practices |
| LCST | Lower critical solution temperature |
| MA-CMCs | Methacrylic anhydride-modified carboxymethyl chitosan |
| mRNAs | Messenger RNAs |
| MW | Molecular weight |
| NAR/β-CD | Naringenin–β-cyclodextrin |
| NG | Nanogel |
| NLG | Nanolipogel |
| OPs | Oyster peptide |
| PCL | Polycaprolactone |
| PCS | Phosphorylated chitosan |
| PEG | Polyethylene glycol |
| PNIPAAm | Poly(N-isopropylacrylamide) |
| PVA | Polyvinyl alcohol |
| QbD | Quality-by-design |
| recNcPDI | Nanogel-encapsulated recombinant NcPDI |
| RNAi | RNA interference |
| RT-PCR | Reverse transcription polymerase chain reaction |
| siRNA | Small interfering RNA |
| TALENs | Transcription activator-like effector nucleases |
| TC | Trimethyl chitosan-cysteine |
| TPP | Tripolyphosphate |
| Tyr | Tyrosine |
| uPA | Urokinase-type plasminogen activator |
| ZFNs | Zinc finger nucleases |